6:14 PM
 | 
Jan 21, 2014
 |  BC Extra  |  Financial News

Argos, Dicerna set IPO terms

Immunotherapy company Argos Therapeutics Inc. (Durham, N.C.) and RNAi company Dicerna Pharmaceuticals Inc. (Watertown, Mass.) set IPO terms on Tuesday. Both companies are seeking to list on NASDAQ. Argos plans to sell 4.3 million shares at $13-$15. At the $14 midpoint, the company would raise $59.5 million and be valued at...

Read the full 241 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >